A therapeutic target that could lead to the development of new treatments for specific blood cancers has been identified by researchers. Using laboratory models, they found that 'switching off' half the gene in the Mpl receptor reduced its expression with the result that the disease did not develop.
A therapeutic target that could lead to the development of new treatments for specific blood cancers has been identified by researchers. Using laboratory models, they found that 'switching off' half the gene in the Mpl receptor reduced its expression with the result that the disease did not develop.
Share this Article
Recommended